Norman Zhennan Lai

Title: The Innovative Contributions of Norman Zhennan Lai

Introduction

Norman Zhennan Lai is a prominent inventor based in N. Potomac, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies and gene therapy methods. With a total of 3 patents, his work has the potential to impact cancer treatment and research.

Latest Patents

One of his latest patents is focused on antibodies and their therapeutic uses. This disclosure teaches antibodies that are useful in methods for detecting and treating human cancer, specifically breast cancer. The novel antibodies described in this patent bind to filamin A and include intrabodies that can be utilized in various therapeutic applications. Another significant patent involves the use of PCBP1 to treat hyperproliferative diseases. This patent provides compositions and methods for using gene therapy to decrease cell migration and metastasis, ultimately reducing tumor mass or burden. The methods disclosed employ plasmids, vectors, and non-viral vectors containing PCBP1 and/or its mutants, which inhibit the expression of cancer biomarkers.

Career Highlights

Throughout his career, Norman has worked with several companies, including Ibex Biosciences, Inc. and Vast Sea Biotechnology, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in biotechnology and cancer treatment.

Collaborations

Norman has collaborated with notable individuals in his field, including Michael Joseph Karlin and Alberto Murat Croci. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Norman Zhennan Lai's contributions to biotechnology and cancer treatment through his innovative patents demonstrate his commitment to advancing medical science. His work continues to inspire future research and development in the field.